Drug Retention Rates and Treatment Discontinuation among Anti-TNF-α Agents in Psoriatic Arthritis and Ankylosing Spondylitis in Clinical Practice

Objective. The study aim was to determine treatment persistence rates and to identify causes of discontinuation in psoriatic arthritis (PsA) and ankylosing spondylitis (AS) patients in clinical practice. Methods. Patients treated with adalimumab (ADA), etanercept (ETA), or infliximab (INF) were retr...

Descripción completa

Detalles Bibliográficos
Autores principales: Fabbroni, Marta, Cantarini, Luca, Caso, Francesco, Costa, Luisa, Pagano, Veronica Anna, Frediani, Bruno, Manganelli, Stefania, Galeazzi, Mauro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2014
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4119698/
https://www.ncbi.nlm.nih.gov/pubmed/25110401
http://dx.doi.org/10.1155/2014/862969

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4119698/
https://www.ncbi.nlm.nih.gov/pubmed/25110401
http://dx.doi.org/10.1155/2014/862969

Ejemplares similares